Easywell Biomedicals, Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was TWD 77.836 million compared to TWD 83.724 million a year ago. Operating loss was TWD 45.244 million compared to TWD 54.252 million a year ago. Net loss was TWD 45.791 million compared to TWD 62.556 million a year ago. Basic loss per share from continuing operations was TWD 0.36 compared to TWD 0.53 a year ago. Basic loss per share was TWD 0.36 compared to TWD 0.6 a year ago.